Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Your breast cancer tests positive for estrogen receptors and progesterone receptors (at least 10% each), but negative for a protein called HER2 (confirm with trial site)
- Your cancer has a low growth rate, shown by a lab test called Ki-67 coming back at less than 20% (confirm with trial site)
- Your cancer has not spread to your lymph nodes
- You are receiving standard treatments such as chemotherapy, radiation, or hormone therapy as recommended by major cancer guidelines
- You and your family have given written consent to take part in the trial
Who may not be able to join:
- You have breast cancer in both breasts at the same time
- You have a type of breast cancer called inflammatory breast cancer
- You are currently pregnant or breastfeeding
- You have a history of another type of cancer
- You have previously had radiation therapy to your chest area
⚠️ Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jianyi Li, MD, Shengjing Hospital
Phone: +8618940257177
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Disease-free survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.